{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:40:48Z","timestamp":1790505648239,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.expneurol.2007.02.010","type":"journal-article","created":{"date-parts":[[2007,2,28]],"date-time":"2007-02-28T12:30:58Z","timestamp":1172665858000},"page":"311-314","source":"Crossref","is-referenced-by-count":54,"title":["Attenuation of MPTP neurotoxicity by rolipram, a specific inhibitor of phosphodiesterase IV"],"prefix":"10.1016","volume":"211","author":[{"given":"Lichuan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel Y.","family":"Calingasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly J.","family":"Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Flint","family":"Beal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2007.02.010_bib1","doi-asserted-by":"crossref","first-page":"15020","DOI":"10.1073\/pnas.95.25.15020","article-title":"Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory","volume":"95","author":"Barad","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2007.02.010_bib2","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1006\/clim.2000.4964","article-title":"The phosphodiesterase inhibitors pentoxifylline and rolipram suppress macrophage activation and nitric oxide production in vitro and in vivo","volume":"98","author":"Beshay","year":"2001","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.expneurol.2007.02.010_bib3","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1046\/j.1471-4159.2000.0742213.x","article-title":"Deficiency of inducible nitric oxide synthase protects against MPTP toxcity in vivo","volume":"74","author":"Dehmer","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2007.02.010_bib4","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0165-5728(00)00265-4","article-title":"The type IV phosphodiesterase specific inhibitor mesopram inhibits experimental autoimmune encephalomyelitis in rodents","volume":"108","author":"Dinter","year":"2000","journal-title":"J. Neuroimmun."},{"key":"10.1016\/j.expneurol.2007.02.010_bib5","doi-asserted-by":"crossref","first-page":"5104","DOI":"10.1073\/pnas.91.11.5104","article-title":"Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat","volume":"91","author":"Frim","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.expneurol.2007.02.010_bib6","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/ana.10659","article-title":"Stilbazulenyl nitrone, a novel antioxidant, is highly neuroprotective in focal ischemia","volume":"54","author":"Ginsberg","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2007.02.010_bib7","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1172\/JCI22831","article-title":"Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment","volume":"114","author":"Gong","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2007.02.010_bib8","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1111\/j.1460-9568.1995.tb01041.x","article-title":"Inhibitors of type IV phosphodiesterases reduce the toxicity of MPTP in substantia nigra neurons in vivo","volume":"7","author":"Hulley","year":"1995","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2007.02.010_bib9","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/ana.20259","article-title":"cAMP response element-binding protein activation in ligation preconditioning in neonatal brain","volume":"56","author":"Lee","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2007.02.010_bib10","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1038\/70918","article-title":"Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson's disease","volume":"5","author":"Liberatore","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2007.02.010_bib11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1227\/00006123-198107000-00006","article-title":"Treatment of acute focal cerebral ischemia with dimethyl sulfoxide","volume":"9","author":"Little","year":"1981","journal-title":"Neurosurgery"},{"key":"10.1016\/j.expneurol.2007.02.010_bib12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1749-6632.1983.tb47308.x","article-title":"Ineffectiveness of DMSO in treating experimental brain ischemia","volume":"411","author":"Little","year":"1983","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2007.02.010_bib13","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1042\/0264-6021:3470571","article-title":"Action of rolipram on specific PDE4 cAMP phosphodiesterase isoforms and on the phosphorylation of cAMP-response-element-binding protein (CREB) and p38 mitogen-activated protein (MAP) kinase in U937 monocytic cells","volume":"347","author":"MacKenzie","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.expneurol.2007.02.010_bib14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0022-510X(99)00050-7","article-title":"Type IV phosphodiesterase inhibition in experimental allergic encephalomyelitis of Lewis rats: sequential gene expression analysis of cytokines, adhesion molecules and the inducible nitric oxide synthase","volume":"164","author":"Martinez","year":"1999","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2007.02.010_bib15","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/sj.npp.1300813","article-title":"Subchronic rolipram delivery activates hippocampal CREB and Arc, enhances retention and slows down extinction of conditioned fear","volume":"31","author":"Monti","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.expneurol.2007.02.010_bib16","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/0003-2697(87)90431-3","article-title":"A fluorometric determination of N-methyl-4-phenylpyridinium ion, using high-performance liquid chromatography","volume":"162","author":"Naoi","year":"1987","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.expneurol.2007.02.010_bib17","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.expneurol.2004.11.030","article-title":"Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons","volume":"192","author":"Porritt","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2007.02.010_bib18","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1073\/pnas.78.2.1001","article-title":"Dimethyl sulfoxide prevents DNA nicking mediated by ionizing radiation or iron\/hydrogen peroxide-generated hydroxyl radical","volume":"78","author":"Repine","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2007.02.010_bib19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0304-3940(97)00915-4","article-title":"Dimethylsulfoxide (DMSO) treatment reduces infarction volume after permanent focal cerebral ischemia in rats","volume":"239","author":"Shimizu","year":"1997","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2007.02.010_bib20","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1471-4159.2005.03060.x","article-title":"Interference of CREB-dependent transcriptional activation by expanded polyglutamine stretches-augmentation of transcriptional activation as a potential therapeutic strategy for polyglutamine diseases","volume":"93","author":"Shimohata","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2007.02.010_bib21","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1227\/00006123-199510000-00018","article-title":"Effects of brain-derived neurotrophic factor on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in monkeys","volume":"37","author":"Tsukahara","year":"1995","journal-title":"Neurosurgery"},{"key":"10.1016\/j.expneurol.2007.02.010_bib22","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.1073\/pnas.0937239100","article-title":"NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease","volume":"100","author":"Wu","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2007.02.010_bib23","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.expneurol.2004.07.012","article-title":"A novel azulenyl nitrone antioxidant protects against MPTP and 3-nitropropionic acid neurotoxicities","volume":"191","author":"Yang","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2007.02.010_bib24","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0028-3908(01)00174-5","article-title":"Suppressive effects of phosphodiesterase type IV inhibitors on rat cultured microglial cells: comparison with other types of camp-elevating agents","volume":"42","author":"Zhang","year":"2002","journal-title":"Neuropharmacology"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488607000878?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488607000878?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T01:58:45Z","timestamp":1546999125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488607000878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0014488607000878"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2007.02.010","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}